Literature DB >> 25346142

Motor symptoms after deep brain stimulation of the subthalamic nucleus.

B Lilleeng1, M Gjerstad, R Baardsen, I Dalen, J P Larsen.   

Abstract

OBJECTIVES: Stimulation of the subthalamic nucleus (STN-DBS) is an established treatment with long-term beneficial effects on motor symptoms in patients with Parkinson's disease (PD). The efficacy of STN-DBS on non-dopaminergic motor symptoms remains less elucidated. In this study, we have examined short- and long-term impacts of STN-DBS on the development of the postural instability and gait difficulties (PIGD) phenotype, freezing of gait (FOG), and falls.
MATERIALS AND METHODS: We collected data from a prospectively followed cohort of patients that had been operated with STN-DBS 6-9 years before final examination and compared our findings to the longitudinal development of the same symptoms in a non-operated, historical reference population.
RESULTS: During short-term follow-up after surgery, we observed a marked improvement in mean UPDRS-motor score from 27 to 18. We also found clear improvements in tremor, bradykinesia, rigidity, and PIGD scores. However, 6-9 years after surgery, all patients had a dominating PIGD pattern of parkinsonism and 50% of the patients had developed FOG and/or had become recurrent fallers. The disease development in a group of patients with PD from the presurgery period had a similar trajectory as among the operated patients. In addition, mean annual change of both bradykinesia and PIGD scores was nearly identical in both study groups while tremor and rigidity had a significant better development in the operated patients.
CONCLUSIONS: We found that STN-DBS induces an acute improvement of PIGD symptoms. The following long-term development was however characterized by a marked progression of non-dopaminergic symptoms.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinson's disease; deep brain stimulation of the subthalamic nucleus; non-dopaminergic

Mesh:

Year:  2014        PMID: 25346142     DOI: 10.1111/ane.12342

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

1.  Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.

Authors:  Chioma Anidi; Johanna J O'Day; Ross W Anderson; Muhammad Furqan Afzal; Judy Syrkin-Nikolau; Anca Velisar; Helen M Bronte-Stewart
Journal:  Neurobiol Dis       Date:  2018-09-06       Impact factor: 5.996

2.  Systemic effects of deep brain stimulation on synergic control in Parkinson's disease.

Authors:  Ali Falaki; Hang Jin Jo; Mechelle M Lewis; Barbara O'Connell; Sol De Jesus; James McInerney; Xuemei Huang; Mark L Latash
Journal:  Clin Neurophysiol       Date:  2018-03-09       Impact factor: 3.708

3.  Longitudinal medication profile and cost savings in Parkinson's disease patients after bilateral subthalamic nucleus deep brain stimulation.

Authors:  Jing Han Ng; Angela An Qi See; Zheyu Xu; Nicolas Kon Kam King
Journal:  J Neurol       Date:  2020-05-04       Impact factor: 4.849

4.  DBS-Edmonton App, a Tool to Manage Patient Expectations of DBS in Parkinson Disease.

Authors:  Kevin Yen; Janis M Miyasaki; Michelle Waldron; Lin Yu; Tejas Sankar; Fang Ba
Journal:  Neurol Clin Pract       Date:  2021-06

Review 5.  Prevalence of freezing of gait in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Wei-Shan Zhang; Chao Gao; Yu-Yan Tan; Sheng-Di Chen
Journal:  J Neurol       Date:  2021-07-08       Impact factor: 4.849

6.  The Neuromodulatory Impact of Subthalamic Nucleus Deep Brain Stimulation on Gait and Postural Instability in Parkinson's Disease Patients: A Prospective Case Controlled Study.

Authors:  Stanislaw Szlufik; Maria Kloda; Andrzej Friedman; Iwona Potrzebowska; Kacper Gregier; Tomasz Mandat; Andrzej Przybyszewski; Justyna Dutkiewicz; Monika Figura; Piotr Habela; Dariusz Koziorowski
Journal:  Front Neurol       Date:  2018-10-31       Impact factor: 4.003

7.  Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson's Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS).

Authors:  Kazunori Sato; Noriaki Aita; Yoshihide Hokari; Eriko Kitahara; Mami Tani; Nana Izawa; Kozo Hatori; Ryota Nakamura; Fuyuko Sasaki; Satoko Sekimoto; Takayuki Jo; Genko Oyama; Taku Hatano; Yasushi Shimo; Hirokazu Iwamuro; Atsushi Umemura; Nobutaka Hattori; Toshiyuki Fujiwara
Journal:  Parkinsons Dis       Date:  2019-08-04

8.  Long-term Efficacy of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A 5-year Follow-up Study in China.

Authors:  Lu-Lu Jiang; Jin-Long Liu; Xiao-Li Fu; Wen-Biao Xian; Jing Gu; Yan-Mei Liu; Jing Ye; Jie Chen; Hao Qian; Shao-Hua Xu; Zhong Pei; Ling Chen
Journal:  Chin Med J (Engl)       Date:  2015-09-20       Impact factor: 2.628

9.  Outcome of subthalamic nucleus deep brain stimulation on long-term motor function of patients with advanced Parkinson disease.

Authors:  Gholam Ali Shahidi; Mohammad Rohani; Mansour Parvaresh; Bahram Haghi-Ashtiani; Maryam Saeedi; Romina Rashedi; Zeynab Noori-Motlagh
Journal:  Iran J Neurol       Date:  2017-07-06

10.  Voltage adjustment improves rigidity and tremor in Parkinson's disease patients receiving deep brain stimulation.

Authors:  Shao-Hua Xu; Chao Yang; Wen-Biao Xian; Jing Gu; Jin-Long Liu; Lu-Lu Jiang; Jing Ye; Yan-Mei Liu; Qi-Yu Guo; Yi-Fan Zheng; Lei Wu; Wan-Ru Chen; Zhong Pei; Ling Chen
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.